FDA.reportPublic FDA data

seladelpar 10 MG Oral Capsule

RxCUI
2690875
RxNorm name
seladelpar 10 MG Oral Capsule
Display name
seladelpar 10 MG Oral Capsule
Full name
seladelpar 10 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LivdelziSELADELPAR LYSINEGilead Sciences, Inc89f79d98-135c-40b2-a585-6996c04e599c2026-02-03Warnings, Adverse reactionsExact identifier
rxcui: 2690875

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
89f79d98-135c-40b2-a585-6996c04e599cseladelpar 10 MG Oral Capsule [PSN] · seladelpar 10 MG Oral Capsule [SCD] · seladelpar 10 MG (equivalent to 14.1 MG seladelpar lysine) Oral Capsule [SY]33These highlights do not include all the information needed to use LIVDELZI safely and effectively. See full prescribing information for LIVDELZI. LIVDELZI ® (seladelpar) capsules, for oral use Initial U.S. Approval: 202420260203